Research location
Vigo
Pontevedra, Spain
Advertisement
Research activity in Vigo
Pontevedra, SpainCureCurrent currently publishes aggregate city-level research activity for this location: 109 trials and 133 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Vigo
109 linked trials · page 2 of 3Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain MetastasisNCT03526900 · 2018-07-07 · 1 site observation
COMPLETED
A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene MutationNCT03439514 · 2018-04-17 · 1 site observation
TERMINATED
Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)NCT03322540 · 2017-12-15 · 1 site observation
COMPLETED
Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer PatientsNCT03081689 · 2017-04-15 · 1 site observation
COMPLETED
Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBCNCT02941926 · 2016-11-30 · 1 site observation
COMPLETED
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)NCT02861014 · 2016-09-09 · 1 site observation
COMPLETED
Observational Study of Obstructive Lung Disease (NOVELTY)NCT02760329 · 2016-07-25 · 2 site observations
COMPLETED
Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS)NCT02776072 · 2016-05-01 · 1 site observation
COMPLETED
Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast CancerNCT02690480 · 2016-02-17 · 1 site observation
UNKNOWN
PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223.NCT02925702 · 2016-02-01 · 1 site observation
UNKNOWN
Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis ConditionNCT02598167 · 2015-12-07 · 1 site observation
COMPLETED
Avelumab in First-line NSCLC (JAVELIN Lung 100)NCT02576574 · 2015-10-29 · 1 site observation
COMPLETED
Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) ParticipantsNCT02342704 · 2014-11-30 · 1 site observation
TERMINATED
Abiraterone Acetate in Combination With Docetaxel After Disease Progression to Abiraterone Acetate in Metastatic Castration Resistant Prostate Cancer.NCT02036060 · 2014-02-07 · 1 site observation
COMPLETED
ASPET Study: An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced Non-Small Cell Lung Cancer Harbouring EGFR Activating MutationsNCT01723878 · 2013-12-30 · 1 site observation
COMPLETED
Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) ParticipantsNCT02006693 · 2013-12-05 · 1 site observation
COMPLETED
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple SclerosisNCT01892722 · 2013-07-26 · 1 site observation
ACTIVE_NOT_RECRUITING
A Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of IllnessNCT01959659 · 2013-05-01 · 1 site observation
COMPLETED
A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)NCT01772472 · 2013-04-03 · 1 site observation
COMPLETED
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based TreatmentNCT01702571 · 2012-11-27 · 1 site observation
COMPLETED
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyNCT01714661 · 2012-10-01 · 1 site observation
COMPLETED
An Observational Study in Clinical Practice Management of Patients With Biological Drugs in MonotherapyNCT01664117 · 2012-06-01 · 1 site observation
COMPLETED
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerNCT01566721 · 2012-05-17 · 1 site observation
COMPLETED
Dose-response Study With Subcutaneous Immunotherapy of an Standardized Dermatophagoides Pteronyssinus (DPT) ExtractNCT01564017 · 2012-05-01 · 1 site observation
COMPLETED
A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid ArthritisNCT01462162 · 2011-09-01 · 1 site observation
COMPLETED
A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate Versus RoActemra/Actemra Monotherapy in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateNCT01399697 · 2011-09-01 · 1 site observation
COMPLETED
Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance TherapyNCT01307488 · 2011-09-01 · 1 site observation
COMPLETED
Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC PatientsNCT01306942 · 2011-07-01 · 1 site observation
COMPLETED
Multicenter Descriptive Study of the Patient Clinical Profile That Begins With Disseminated Her 2 + Breast Cancer or Develops a Metastasis After or During the Adjuvant TherapyNCT01645059 · 2011-07-01 · 1 site observation
COMPLETED
An Observational Study on Patients With Non-Squamous NSCLC Who Reached A Long PFS After Avastin (Bevacizumab)-Based First-Line TherapyNCT01343914 · 2011-06-01 · 1 site observation
COMPLETED
Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT)NCT01284608 · 2011-03-01 · 1 site observation
COMPLETED
Observational Study to Characterize the Incidence of EGFR Mutation Positive and Advanced NSCLC PatientsNCT01717105 · 2011-03-01 · 3 site observations
UNKNOWN
An Non-Interventional Study of Patients With Persistent Symptoms of SchizophreniaNCT01634542 · 2011-02-01 · 1 site observation
COMPLETED
Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung CancerNCT01244191 · 2011-01-11 · 1 site observation
TERMINATED
An Observational Study of Dosage Patterns in Routine Clinical Practice in Patients With Rheumatoid Arthritis (ACT-LIFE)NCT01338545 · 2010-07-01 · 1 site observation
COMPLETED
Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)NCT01081496 · 2010-03-01 · 1 site observation
COMPLETED
Impact of Morning Symptoms in Clinical Control of Chronic Obstructive Pulmonary Disease (COPD)NCT01266395 · 2010-01-01 · 1 site observation
COMPLETED
Efficacy of a Disease Management Program in Very Old Patients With Heart FailureNCT01076465 · 2009-10-01 · 1 site observation
COMPLETED
A Study Comparing Infusion Rates of Tocilizumab in Patients With Moderate to Severe Rheumatoid ArthritisNCT00887341 · 2009-05-01 · 2 site observations
COMPLETED
A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid ArthritisNCT00853385 · 2009-05-01 · 1 site observation
COMPLETED
Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ PatientsNCT00841828 · 2009-02-01 · 1 site observation
COMPLETED
A Study of Avastin (Bevacizumab) in Combination With Taxane-based Chemotherapy as First Line Treatment in Patients With HER-2 Negative Breast CancerNCT00846027 · 2009-01-01 · 1 site observation
COMPLETED
Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With LipoatrophyNCT00865007 · 2008-12-01 · 1 site observation
COMPLETED
Chronotherapy with Low-dose Aspirin for Primary PreventionNCT00725127 · 2008-10-01 · 6 site observations
ACTIVE_NOT_RECRUITING
Four Dimensions in SchizophreniaNCT00782899 · 2008-10-01 · 1 site observation
COMPLETED
Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk AssessmentNCT00741585 · 2008-09-01 · 7 site observations
COMPLETED
Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected PatientsNCT00526448 · 2007-06-01 · 2 site observations
UNKNOWN
Expanded Access Program for Maraviroc At Multiple CentersNCT00426660 · 2007-02-01 · 1 site observation
COMPLETED
Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or Mild Essential HypertensionNCT00449618 · 2007-01-01 · 2 site observations
TERMINATED
Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive PatientsNCT01684787 · 2006-09-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.